| For anyone interested: https://blogs.sciencemag.org/pipeline/archives/2021/02/02/my... Around the time of this post I tried to get a bit more information on this, and ... well, here's the rabbit hole: - https://www.youtube.com/watch?v=68p3qAm4i7U Use lithography to create the mold, then cure it, then put it into a pure O2 enivornment, then drop it on a glass plate and you just plasma glued the silicone and the glass. - https://www.youtube.com/watch?v=EYuyRUjnTgc - https://www.youtube.com/watch?v=EjyM8sNplm4 - https://www.youtube.com/watch?v=wTmgqFCIbsA I still have no idea where the bottleneck actually is. Derek Lowe claimed that the manufacturers of the microfluidics devices are. Which is likely, because hacking together something in/for a lab is very different than getting it ready for "FDA GMP [good manufacturing practices] approval" ... but at the same time there are thousands of people dying every day, and I'd like to see the extraordinary evidence to support the extraordinary claim that it's "impossible" to scale up vaccine manufacturing. (Impossible here meaning that it's impossible to get to the same necessary purity and control.) |
But, having more capacity in a year's time, doesn't necessarily save any lives, since the mRNA vaccines are not the best fit for most of the world anyway, as they require two doses per person and are more demanding in the refrigeration requirements. The adenovirus vaccines, despite the one-in-a-quarter-million side affects, are much more likely to be usable in quantity in most of the world.
So, you could get more capacity up in a year's time, when it won't be needed in the rich world and won't be useful in the rest of the world.
My guess is Moderna just made this announcement to try to dispel the idea that their patent enforcement was somehow getting people killed.